[Establishment and application of a drug screening model for anti-prostate cancer agents targeting androgen receptor].

Androgen receptor(AR) plays an important role in the maintenance of prostate function and development of prostate cancer. AR is the key target in the therapy of prostate cancer. In this study, a cell-based screening assay was established by dual-luciferase reporter system to analyze the activity of AR. In the screening assay, we detected the anti-prostate cancer activities of rhodiola root extract, wild kiwifruit root extract and tripterygium wilfordii root extract, which may provide a new strategy for the treatment of prostate cancer.

[1]  F. Claessens,et al.  Emerging mechanisms of enzalutamide resistance in prostate cancer , 2014, Nature Reviews Urology.

[2]  Rikard Larsson,et al.  The role of PI3K/AKT-related PIP5K1α and the discovery of its selective inhibitor for treatment of advanced prostate cancer , 2014, Proceedings of the National Academy of Sciences.

[3]  Gang Shao,et al.  A clinically relevant androgen receptor mutation confers resistance to second-generation antiandrogens enzalutamide and ARN-509. , 2013, Cancer discovery.

[4]  Joshua M. Korn,et al.  An F876L mutation in androgen receptor confers genetic and phenotypic resistance to MDV3100 (enzalutamide). , 2013, Cancer discovery.

[5]  V. Arora,et al.  Overcoming mutation-based resistance to antiandrogens with rational drug design , 2013, eLife.

[6]  Zhongbo Liu,et al.  Rhodiola rosea extracts and salidroside decrease the growth of bladder cancer cell lines via inhibition of the mTOR pathway and induction of autophagy , 2012, Molecular carcinogenesis.

[7]  Jinming Zhou,et al.  Antiandrogenic, maspin induction, and antiprostate cancer activities of tanshinone IIA and its novel derivatives with modification in ring A. , 2012, Journal of medicinal chemistry.

[8]  K. Iguchi,et al.  Androgen receptor W741C and T877A mutations in AIDL cells, an androgen-independent subline of prostate cancer LNCaP cells , 2011, Tumor Biology.

[9]  Shuifeng Qiu,et al.  Salidroside induces cell-cycle arrest and apoptosis in human breast cancer cells. , 2010, Biochemical and biophysical research communications.

[10]  H. Kung,et al.  Aberrant activation of the androgen receptor by NF-kappaB2/p52 in prostate cancer cells. , 2010, Cancer research.

[11]  H. Scher,et al.  Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer , 2009, Science.

[12]  Clement Ip,et al.  Androgen receptor signaling intensity is a key factor in determining the sensitivity of prostate cancer cells to selenium inhibition of growth and cancer-specific biomarkers , 2005, Molecular Cancer Therapeutics.